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Abstract
The mechanism by which Hq alters the kinetics of the Hq-coupled peptide transporters PEPT 1 and PEPT 2 was
 .investigated in two different cell lines which differentially express these transporters, namely Caco-2 cells PEPT 1 and
 . qSKPT cells PEPT 2 . The effects of H on the affinity and the maximal velocity of Gly-Sar uptake were analyzed in these
cells under identical conditions. In both cells, Hq influenced only the maximal velocity of uptake and not the apparent
q  .affinity. The effects of H on the IC values i.e., concentration necessary to cause 50% inhibition of the cationic50
dipeptide Ala-Lys and the anionic dipeptide Ala-Asp for inhibition of Gly-Sar uptake were also investigated. Hq did not
change the IC value for Ala-Lys but did decrease the IC value for Ala-Asp considerably. The influence of50 50
 .diethylpyrocarbonate DEP on the kinetic parameters of PEPT 1 and PEPT 2 was then studied. Histidyl residues are the
most likely amino acid residues involved in Hq binding and translocation in Hq-coupled transport systems and DEP is
known to chemically modify histidyl residues and block their function. DEP treatment altered the maximal velocity of
 .Gly-Sar uptake but had no effect on its K Michaelis-Menten constant or the IC values of Ala-Lys or Ala-Asp for thet 50
inhibition of Gly-Sar uptake. It is concluded that Hq stimulates PEPT 1 and PEPT 2 primarily by increasing the maximal
velocity of the transporters with no detectable influence on the substrate affinity.
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Abbreviations: Gly-Sar, glycylsarcosine; Ala-Lys, alanylly-
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methane; EDTA, ethylenediamine tetraacetic acid; PBS, phos-
phate-buffered saline; SDS, sodium dodecyl sulfate; BCECF-AM,
X X  .  .2 ,7 -bis carboxyethyl -5 6 -carboxyfluorescein acetoxymethyl
ester.
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1. Introduction
Ion-coupled solute transport across biological
membranes is one of the fundamental principles in
biology. Many nutrients are transported into the cells
by carriers which are driven by transmembrane ion
gradients. The ions are cotransported with substrates
and the downhill movement of the ions is energeti-
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cally coupled to the uphill movement of the sub-
strates. Naq and Hq have been identified as the most
important coupling ions for transport systems which
are capable of active transport. Naq serves as the
cotransportable ion for a variety of transport systems
involved in the uphill transport of glucose, amino
acids, vitamins, and neurotransmitters. Hq-coupled
solute transport systems were first described in bacte-
ria but later also found to occur in animal cells.
Examples of Hq-coupled solute transport systems in
animal cells include those involved in the transport of
w x w xsmall peptides 1–3 , monocarboxylates 4 , and cer-
w xtain amino acids 5–7 .
The ion-coupled transport systems are activated by
their respective coupling ions due, in most cases, to
the ability of the ions to increase the affinity of the
transport systems for their substrates. This has been
documented in animal cells, for example, in the
q w xfollowing cases: Na rproline cotransporter 8 ,
q w x qNa rglucose cotransporter 9 , Na rsuccinate co-
w x q w xtransporter 10 , Na rglycine cotransporter 11 ,
q w x q yNa rcarnitine cotransporter 12 , Na plus Cl -cou-
w xpled neurotransmitter transporters 13,14 , and
q w x qH rleucine cotransporter 15 . Several H -coupled
transport systems in bacteria have also been shown to
be activated by the coupling ion by a similar mecha-
w xnism 16 . Surprisingly, in the case of the intestinal
Hqrpeptide cotransporter, the cotransported ion Hq
was found to activate the transport system by increas-
ing the maximal velocity with no significant effect on
w xthe affinity 17 . Similar results were obtained with
the renal Hqrpeptide cotransporter when histidyl
residues, the most likely amino acid residues to be
involved in the binding and translocation of Hq, were
 .chemically modified with diethylpyrocarbonate DEP
w x18 . In the following years, however, contradictory
results have been published regarding the influence
of Hq andror DEP on the kinetic parameters of the
q w xintestinal H rpeptide cotransporter. Kato et al. 19
have reported that modification of histidyl residues
with DEP in rabbit intestinal brush border mem-
branes decreases the V without affecting the Kmax t
for cephardine, a zwitterionic substrate for the
Hqrpeptide cotransporter. A similar conclusion was
w x qdrawn by Thwaites et al. 20 who found that H
activates the peptide transport system in the Caco-2
intestinal cell line by increasing the V with nomax
effect on K for the dipeptide substrate Gly-Sar. Int
w xcontrast, Kramer et al. 21 found that DEP treatment
of rabbit intestinal brush border membranes increases
the K for cephalexin, also a zwitterionic substratet
for the Hqrpeptide cotransporter, without influenc-
ing the V . Corroborating the conclusions of Kramermax
et al. were the findings that an acidic pH increases
the affinity of the intestinal Hqrpeptide cotransporter
w x w xfor its substrates glycylglycine 22 and cefixime 23 .
Therefore, it is not clear at this time whether Hq
activates the peptide transport system in the intestine
by increasing the substrate affinity or by increasing
the maximal velocity. Interestingly, there appears to
be no such controversy with regard to the renal
Hqrpeptide cotransporter. Renal brush border mem-
branes possess two different peptide transport sys-
tems, one with low-affinity and the other with high-
w xaffinity for peptide substrates 24,25 . Daniel et al.
w x q25 have elegantly shown that H activates both
these systems by increasing the V without affect-max
ing the substrate affinity. These results have been
recently reproduced with the high-affinity peptide
w xtransporter cloned from rabbit kidney 26 .
Recent cloning studies have clearly established
that the intestinal peptide transporter is structurally
and functionally distinct from the high-affinity pep-
w xtide transporter expressed in the kidney 26–34 . We
have identified cell culture model systems to individ-
w xually study these two transporters 35–37 . The hu-
man colon carcinoma cell line Caco-2 expresses the
intestinal low-affinity Hqrpeptide cotransporter
 .PEPT 1 and the rat proximal tubular cell line SKPT
expresses the renal high-affinity Hqrpeptide cotrans-
 .porter PEPT 2 . In the present investigation, we
studied the influence of the coupling ion Hq on the
kinetic parameters of PEPT 1 and PEPT 2 using these
two cultured cell lines under identical experimental
conditions. This was done by measuring the maximal
velocity and substrate affinity for structurally diverse
substrates at two different Hq concentrations and
also with or without modifying the histidyl residues
in PEPT 1 and PEPT 2 by DEP treatment.
2. Materials and methods
2.1. Materials
The human colon carcinoma cell line Caco-2 was
obtained from the American Type Culture Collection
( )M. Brandsch et al.rBiochimica et Biophysica Acta 1324 1997 251–262 253
 .Rockville, MD, USA . The rat renal proximal tubu-
w xlar epithelial cell line SKPT-0193 Cl.2 36 was
established by SV40 transformation of isolated cells
from the proximal tubule and was provided by Dr.
Ulrich Hopfer Case Western Reserve University,
.Cleveland, OH, USA . Minimum Essential Medium
 .MEM with Earle’s salts and L-glutamine was pur-
 .chased from Mediatech Washington D.C., USA .
Dulbecco’s Modified Eagle Medium:Nutrient Mix-
 .  . ture F12 Ham 1:1 DMEMrF12 with Hepes 15
.mM and L-glutamine, MEM non-essential amino
 .acids, penicillin 10 000 unitsrml -streptomycin
 .10 000 mgrml , and trypsin were obtained from Life
 .Technologies Gaithersburg, MD, USA . Ala-Lys,
Ala-Asp, DEP, EDTA, dexamethasone, apotransfer-
rin and fetal bovine serum were purchased from
 .Sigma St. Louis, MO, USA . Recombinant insulin
 .was from Novo Nordisk Denmark and epidermal
growth factor from Upstate Biotechnology, Inc. Lake
.Placid, NY, USA . Cephalexin was a generous gift
from Dr. T. Hoshi, University of Shizioka, Shizioka,
w 14 x w 14 x Japan. 2- C Glycyl 1- C sarcosine specific ra-
.dioactivity 108 mCirmmol was obtained from Cam-
 .bridge Research Biochemicals Cleveland, UK .
2.2. Cell culture
 .Caco-2 cells passage 95 to 127 were maintained
in 75 cm2 culture flasks at 378C and 5% CO . MEM2
supplemented with 10% fetal bovine serum, 1% peni-
cillin-streptomycin and 1% MEM non-essential amino
acids was used as culture medium. Cells were grown
to confluence and released by treatment with
PBSrEDTA for 5 min followed by trypsin treatment
 .0.25% trypsin and 0.5 mM EDTA in PBS for -10
s and subcultured in 35-mm disposable Petri dishes.
With a starting cell density of 1=106 cellsrdish, the
cultures reached confluence the next day. Medium
was changed every day. Uptake experiments were
carried out four days after seeding because our previ-
ous studies have shown that the peptide transporter
activity, expressed as Gly-Sar uptakermg of protein,
w xwas maximal under these culture conditions 35 .
SKPT cells at passage number 87 to 101 were
maintained in 75-cm2 culture flasks at 378C in a
humidified atmosphere with 5% CO . They were2
w xcultured as described previously 36 in DMEMrF12
 .medium supplemented with fetal bovine serum 10% ,
 .  .penicillin-streptomycin 1% , insulin 5 mgrml ,
 .  .dexamethasone 4 mgrml , apotransferrin 5 mgrml ,
 .and epidermal growth factor 10 ngrml . Cells grown
to confluence were released by incubation in
PBSrEDTA for 10 min followed by trypsinization
 .0.25% trypsin and 0.5 mM EDTA in PBS for 10 s
and subcultured in 35-mm disposable Petri dishes.
The medium was replaced every day. With a starting
cell density of 1=106 cells per dish, the cultures
reached confluence within 20 h. Uptake was mea-
sured in these cells four days after seeding.
2.3. Cell treatment
Confluent monolayers of Caco-2 cells or SKPT
cells were treated with DEP and these treatments
were done at room temperature for 10 min in pH 7.5
buffer. DEP was mostly added at a final concentra-
tion of 0.4 mM to Caco-2 cells and 0.1 mM to SKPT
cells. The vehicle for DEP used for the controls was
ethanol. Medium for DEP-treatment was prepared
fresh for each single dish due to concerns regarding
the stability of DEP.
2.4. Uptake measurement
Uptake of Gly-Sar was determined as described
w xpreviously 35–37 . The uptake medium was 25 mM
 . MesrTris pH 6.0 , or 25 mM HepesrMesrTris pH
.7.0 , containing 140 mM NaCl, 5.4 mM KCl, 1.8
mM CaCl , 0.8 mM MgSO and 5 mM glucose. The2 4
pH 7.0 uptake buffer was prepared by mixing the
MesrTris pH 6.0 uptake buffer with HepesrTris pH
7.5 uptake buffer to a final pH of 7.0.
Uptake was initiated by removing the medium or
the treatment buffer, and washing the monolayers for
1 min in the respective uptake buffer pH 6.0 or pH
.7.0 . After that, 1 ml of uptake medium containing
radiolabeled Gly-Sar was added. The concentration of
radiolabeled Gly-Sar in most experiments was 10
mM for Caco-2 cells and 5 mM for SKPT cells. In
addition, the uptake medium contained increasing
concentrations of Gly-Sar, Ala-Lys, Ala-Asp or
cephalexin. After dissolving the peptides, the pH of
medium was corrected before preparing the required
dilutions. After incubation for 10 min, the uptake
buffer was removed and the monolayers were quickly
washed four times with ice-cold uptake buffer, dis-
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solved with 1 ml of 0.2 M NaOH containing 1% SDS
and transferred to scintillation vials for quantitation
of radioactivity by liquid scintillation spectrometry.
For each experiment, the samples for protein mea-
surement were prepared and measured as described
w xearlier 35,36 .
For the calculation of the kinetic parameters of
Gly-Sar uptake, the non-saturable uptake component
was determined by measuring the uptake of radiola-
beled Gly-Sar in the presence of an excess amount of
unlabeled Gly-Sar 50 mM in Caco-2, 10 mM in
.SKPT cells and also by analysis of total Gly-Sar
uptake according to a transport model describing one
saturable system plus one non-saturable system. Both
methods gave virtually identical values for the non-
saturable component. This component was subtracted
from the total uptake to calculate the saturable car-
.rier-mediated component. The values for the sat-
urable component were used for construction of
Eadie-Hofstee plots.
2.5. Assessment of Gly-Sar hydrolysis
Caco-2 cells and SKPT cells were incubated for 10
min at pH 6.0 in the presence or in the absence of 1
mM Gly-Sar. At the end of the incubation, the
medium was aspirated and saved for amino acid
analysis. The cell monolayers were washed once with
the uptake buffer, following which 0.5 ml of 4%
sulfosalicylic acid was added to the dish to lyse the
cells and to precipitate cellular proteins. The lysates
were centrifuged and the supernatants saved for amino
acid analysis. Concentrations of Gly-Sar, glycine and
sarcosine in the samples were determined using an
 .amino acid analyzer Beckman, Model 7300 .
2.6. Monitoring of intracellular pH
 .The intracellular pH pH was monitored in SKPTi
cells using BCECF as described by Paradiso et al.
w x38 . Cells were loaded with 2.5 mM of BCECF-AM
and the video images of BCECF fluorescence at 490
nm and 440 nm were monitored by a camera. The
emission bandpass was fixed at 520–550 nm. The
ratio of fluorescence at 490 nm to fluoroscence at
440 nm was taken as a measure of pH . The ratio wasi
continuously recorded when the cells were exposed
 .to the uptake buffer pH 7.5 for 5 min, then to the
 .uptake buffer pH 6.0 for 5 min and then to the
 .uptake buffer pH 6.0 containing 10 mM nigericin
for 10 min.
2.7. Statistics
Experiments were routinely made in duplicate and
each experiment was repeated two to three times. The
results are expressed as means"S.E.M. The kinetic
constants were calculated by non-linear regression
methods using the Fig. P 6.0 program Biosoft,
.Cambridge, UK and confirmed by linear regression
of the Eadie-Hofstee plot. The calculated parameters
K and V are shown with their S.E.M. IC valuest max 50
i.e., concentration of the unlabeled compound neces-
sary to inhibit 50% of radiolabeled glycylsarcosine
.carrier-mediated uptake were also determined by
non-linear regression methods using the equation for
an asymmetric sigmoid allosteric Hill kinetics; linear
.  . dose vs. effect : y s Min q Max-Min r 1 q
 . -P..XrIC . Statistical analysis was done by the50
non-parametric two-tailed U-test, and a P-value of
less than 0.05 was considered statistically significant.
3. Results and discussion
3.1. Effect of an inwardly directed H q gradient on
the kinetic parameters of Gly-Sar uptake in intestinal
and renal cells
It has been shown in earlier studies that in both
w x w xCaco-2 cells 35 and SKPT cells 36 the Gly-Sar
uptake is driven by an inwardly directed Hq gradient,
is linear for at least up to 10 min, and is mediated by
a single uptake system in each cell type. However,
the peptide transport system in Caco-2 cells is the
low-affinity system PEPT 1 and the peptide transport
system in SKPT is the high-affinity system PEPT 2.
We have established by reverse transcription-coupled
PCR and by Northern blot analysis that Caco-2 cells
do not express PEPT 2 and that SKPT cells do not
w xexpress PEPT 1 37 .
Gly-Sar is widely used as a substrate in peptide
transport studies because it is highly resistant to
hydrolysis to plasma membrane peptidases. We in-
vestigated whether this dipeptide is also resistant to
intracellular peptidases in Caco-2 cells as well as in
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SKPT cells. The cells were incubated in the absence
and in the presence of 1 mM Gly-Sar at pH 6.0 for 10
min. Intracellular and medium concentrations of
glycine, sarcosine, and Gly-Sar were then measured.
There was no evidence of hydrolysis of Gly-Sar in
the medium because glycine and sarcosine were un-
detectable following the incubation. The intracellular
concentrations of glycine, sarcosine, and Gly-Sar are
given in Table 1. It is clear that Gly-Sar, following
transport into the cells, remained mostly intact, as
evidenced from minimal difference in glycine and
sarcosine concentrations between the cells incubated
in the absence of Gly-Sar and the cells incubated in
the presence of Gly-Sar.
Using Caco-2 cells and SKPT cells as model
systems, we performed in the present study detailed
kinetic analyses to determine unequivocally the ki-
netic nature of the Hq gradient-dependent activation
of peptide transport activity mediated by PEPT 1 and
PEPT 2. Uptake of Gly-Sar was measured for 10 min
over a concentration range of 0.1–5 mM in Caco-2
cells and 0.01–0.5 mM in SKPT cells at an outside
pH of either 6.0 or 7.0. The diffusional component of
uptake was determined as described in Section 2.
This component was subtracted from total uptake to
calculate mediated uptake. The rate of mediated up-
take was linear in both cells over the incubation
period of 10 min, indicating that initial uptake rates
were measured under the experimental conditions.
Table 1
Intracellular content of glycine, sarcosine, and Gly-Sar in Caco-2
cells and SKPT cells after exposure to Gly-Sar




Without exposure to Gly-Sar 13"0 ND 0.8"0.2
With exposure to Gly-Sar 20"1 ND 339"15
SKPT cells
Without exposure to Gly-Sar 396"10 ND 1.5"0
With exposure to Gly-Sar 415"4 ND 84"3
Cells were incubated for 10 min at pH 6.0 in the absence or in
the presence of 1 mM Gly-Sar. At the end of incubation, the cell
monolayers were washed and then lysed with 4% sulfosalicylic
acid. The lysates were centrifuged to remove precipitated proteins
and the supernatants were used for amino acids analysis. ND, not
detectable.
Fig. 1. Effect of a Hq gradient on the saturation kinetics of
 .  .Gly-Sar uptake in Caco-2 cells A and SKPT cells B . Uptake
of Gly-Sar concentration range, 0.25 to 5 mM in Caco-2 and 10
.to 500 mM in SKPT; uptake time, 10 min was measured in
 .confluent cell cultures at an outside pH of 7.0 v or pH 6.0
 .‘ . The values are means"S.E.M. for 4–6 determinations.
They represent saturable uptake values after correction for non-
saturable component. If not shown, error bars are smaller than the
symbols. Insets: Eadie-Hofstee transformations of the data.
The relationship between the rate of mediated uptake
and substrate concentration was found to be hyper-
bolic under both pH conditions in Caco-2 cells Fig.
.  .1A as well as in SKPT cells Fig. 1B . The experi-
mental data were found to fit best for an uptake
model describing a single transport system. When
expressed as Eadie-Hofstee plots uptake ratersub-
. strate concentration versus uptake rate , the data Fig.
.  2 .1A,B, insets yielded straight lines r )0.95 . De-
termination of kinetic parameters from the data indi-
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Fig. 2. Monitoring of intracellular pH in SKPT cells. Cells were
 .loaded with the acetoxymethyl ester of BCECF 2.5 mM and the
fluorescence was monitored at 490 nm and 440 nm with the
emission bandpass fixed at 520–550 nm. The florescence mea-
surements were made at four different areas of the cell monolayer
and the ratio of fluorescence at 490 nm to fluorescence at 440 nm
 .mean"S.E.M. for the four different areas is given as a measure
of intracellular pH. The measurements were made continuously
when the cell monolayer was exposed to the uptake buffer pH
.  .7.5 for 5 min, then to the uptake buffer pH 6.0 for 5 min and
 .then to the uptake buffer pH 6.0 containing 10 mM nigericin
for 10 min.
cated clearly that increasing the Hq concentration
outside the cells resulted in an increase of the maxi-
mal velocity of Gly-Sar transport without changing
significantly the affinity of the carrier for Gly-Sar. In
Caco-2 cells, the apparent Michaelis-Menten constant
 .K for the uptake process was 1.0"0.1 mM at pHt
 .6.0 and 1.2"0.2 mM at pH 7.0 Table 2 . The
 .maximal velocity V of Gly-Sar uptake, however,max
was 13.7"0.3 nmolr10 min per mg of protein at pH
6.0 and 5.8"0.3 nmolr10 min per mg of protein at
pH 7.0. Similar results were obtained in SKPT cells.
In these renal cells, the apparent Michaelis-Menten
 .constant K for the uptake process was 74.0"3.2t
mM at pH 6.0 and 76.8"11.4 mM at pH 7.0 Table
.  .2 . The maximal velocity V of Gly-Sar uptake,max
however, was 0.99"0.02 nmolr10 min per mg of
protein at pH 6.0 and 0.39"0.02 nmolr10 min per
mg of protein at pH 7.0. Therefore, these data give
no evidence for an effect of Hq on the affinity of the
carrier protein to its substrate Gly-Sar in the intestinal
as well as in the renal cell line.
Monitoring of pH in BCECF-loaded cells indi-i
cated that changing the extracellular pH from 7.5 to
 .6.0 did not alter pH Fig. 2 . The experimentali
technique was validated by the observed acidification
of pH as evidenced from the increase in the ratio ofi
fluorescence at 490 nm to fluorescence at 440 nm
when the cells were exposed to pH 6.0 in the pres-
ence of nigericin.
3.2. Effect of an inwardly directed H q gradient on
the IC ˝alues of Ala-Lys and Ala-Asp for inhibition50
of Gly-Sar uptake in intestinal and renal cells
Gly-Sar is a neutral dipeptide which exists pre-
dominantly as a zwitterion in the pH range 6.0–7.0.
Table 2
q w14 xEffect of H and DEP on the IC values for different peptides for the inhibition of C glycylsarcosine uptake in Caco-2 cells and50
SKPT cells
 .  .Inhibitor Caco-2: IC mM SKPT: IC mM50 50
pH DEP pH DEP
6.0 7.0 y q 6.0 7.0 y q
Glycylsarcosine 1.01"0.04 1.21"0.17 0.83"0.1 0.76"0.09 74.0"3.2 76.8"11.4 64.1"9.9 62.3"4.5
Alanyllysine 0.21"0.02 0.20"0.03 0.24"0.01 0.23"0.05 13.7"0.7 10.0"1.1 10.3"3.3 6.30"0.8
Alanylaspartate 0.19"0.02 1.62"0.33 0.18"0.01 0.24"0.03 15.6"3.3 26.3"2.8 10.6"0.6 8.4"1.4
Cephalexin – – 15.0"4.3 11.7"6.6 – – 72.6"0.8 66.4"8.8
 . w14 x  .Uptake 10 min of C glycylsarcosine 10 mM in Caco-2, 5 mM in SKPT cells was measured, in one set of experiments, at pH 6.0 or
pH 7.0 and, in another set of experiments, at pH 6.0, but after a 10-min treatment with or without DEP in pH 7.5 buffer at a concentration
 .  .of 0.4 mM Caco-2 or 0.1 mM SKPT . Concentration of unlabeled compounds was varied between 0 and 10 mM. The values given
 ."S.E.M. for IC were determined from the dose–response data by nonlinear regression analysis of the data shown in Figs. 1, 3, 5 and50
6.
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To determine whether the observed lack of effect of
the Hq gradient on K is unique only to neutralt
peptide substrates or is also true for other structurally
diverse peptide substrates, we investigated the po-
 .tency of a cationic dipeptide Ala-Lys and an an-
 .ionic dipeptide Ala-Asp to inhibit Gly-Sar uptake at
two different extracellular pH values, 6.0 and 7.0. We
could not determine the affinity of the peptide trans-
porters for these peptides directly by measuring their
uptake because of nonavailability of these peptides in
radiolabeled form. Instead, we analyzed the ability of
these peptides to inhibit the uptake of radiolabeled
Gly-Sar. By this approach, we were able to estimate
the IC values concentration of the peptides neces-50
.sary to inhibit 50% of Gly-Sar uptake and K valuesi
 .inhibition constant of these peptides as indicators of
their respective affinity to the peptide transport sys-
tems. As shown in Fig. 3A,B, the Gly-Sar uptake is
two- to three-fold higher at pH 6.0 than at pH 7.0.
Moreover, Ala-Lys and Ala-Asp are substrates with a
much higher affinity than Gly-Sar for both PEPT 1
and PEPT 2. In the intestinal cell line, where the K t
value for Gly-Sar uptake is 1 mM, the IC values for50
Ala-Lys and Ala-Asp at pH 6.0 are 0.21 and 0.19
 .mM respectively Table 2 . Although the potency of
these two peptides to inhibit Gly-Sar uptake in SKPT
cells is several-fold higher than in Caco-2 cells, the
relative difference between the affinity for Gly-Sar
and the affinity for these peptides is similar in both
cell types. In the SKPT cell line, the K for Gly-Sart
is 75 mM, and the IC values for Ala-Lys and50
Ala-Asp at pH 6.0 are 14 and 16 mM respectively
 .Table 2 . More important, however, is the effect of
the Hq gradient on these IC values. As shown50
Table 2, the Hq gradient does not change the IC50
values for Ala-Lys in Caco-2 cells and in SKPT cells,
indicating that the inwardly directed Hq gradient
does not influence the affinity of PEPT 1 and PEPT 2
for the cationic dipeptide Ala-Lys. In the case of
Ala-Asp, however, decreasing the Hq concentration
outside the cells has dramatic consequences for the
inhibition constants both in intestinal as well as in
renal cells. In Caco-2 cells, the IC value increases50
by 8-fold and in SKPT cells by 2-fold when the pH is
changed from 6.0 to 7.0. There are two possible
explanations for the results obtained with Ala-Asp.
An inwardly directed Hq gradient may influence the
affinity of the peptide transporter for this peptide. But
Fig. 3. Effect of a Hq gradient on the inhibition of Gly-Sar
 .uptake by Ala-Lys and Ala-Asp in Caco-2 cells A and SKPT
 . cells B . Uptake of radiolabeled Gly-Sar 10 mM in Caco-2, 5
.mM in SKPT for 10 min was measured in confluent cell cultures
 .  .at an outside pH of 7.0 v,B or pH 6.0 ‘, I in the presence
 . of increasing concentrations of Ala-Lys ‘, v or Ala-Asp I,
.B . The values are means"S.E. for 3–6 determinations. If not
shown, error bars are smaller than the symbols.
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this is unlikely because a similar phenomenon is not
apparent for the other two dipeptide substrates Gly-Sar
and Ala-Lys. There is no obvious reason to believe
that such an effect of the Hq gradient on the affinity
is unique to the anionic dipeptide Ala-Asp. A more
plausible explanation is that the changes in the rela-
tive ratio of different ionic species of Ala-Asp which
is expected to differ significantly at pH 6.0 versus pH
7.0 are responsible for the observed effects. This can
happen if the peptide transporters show different
affinities to different ionic species of a given peptide
substrate. Given the data that the change of pH from
6.0 to 7.0 has much more dramatic effect on the IC50
values for Ala-Asp in Caco-2 cells than in SKPT
cells, this would then mean that PEPT 2 expressed in
SKPT cells is much more tolerant than PEPT 1
expressed in Caco-2 cells towards changes in the
ionic nature of a given peptide substrate.
3.3. Inhibition of Gly-Sar uptake in Caco-2 cells and
SKPT cells by DEP: dose–response relationship
Several transport systems which are energized by a
transmembrane Hq gradient possess specific histidyl
residues that are critical for their catalytic activity.
Examples of these transport systems include NaqrHq
w x q w xexchanger 39,40 , organic cationrH antiporter 41 ,
w xand folate transporter 42 in animal tissues. The
Escherichia coli Lac permease, a prototypical Hq-
coupled transport system has been extensively stud-
ied with regard to the role of critical histidyl residues
in the binding and translocation of the cotransported
q w xH 43,44 . We have shown several years ago that
the renal Hq-coupled peptide transporter possesses
w xcritical histidyl residues 18 . This conclusion was
based on the data that chemical modification of his-
tidyl residues with DEP leads to inactivation of the
transporter. The essential nature of histidyl residues
in the intestinal Hq-coupled peptide transporter has
w xbeen subsequently demonstrated 19,21 . The unique-
ness of the histidyl residue resides in the pK value of
6.5 for the imidazole group of its side chain which is
very close to the physiological pH. This characteristic
renders the histidyl residues capable of easily accept-
ing and releasing Hq under physiological conditions.
Therefore, the critical histidyl residues are the most
likely amino acid residues involved in the binding
and translocation of Hq in PEPT 1 and PEPT 2.
Fig. 4. Dose–response relationship of the effect of DEP on
 .  .Gly-Sar uptake in Caco-2 cells A and SKPT cells B . Cells
were treated with DEP in pH 7.5 buffer for 10 min before uptake.
 .Uptake of radiolabeled Gly-Sar 5 mM in both cell lines, 10 min
was measured in confluent cell cultures at an outside pH 6.0. The
values are means"S.E.M. for 3–4 determinations. If not shown,
error bars are smaller than the symbols.
Modification of these histidyl residues with DEP
makes them incapable of being a Hq acceptorrdonor.
Therefore, an alternative approach to delineate the
mechanism of activation of PEPT 1 and PEPT 2 by
Hq is to investigate the influence of DEP modifica-
tion of histidyl residues on the kinetic parameters of
these transport systems while keeping the extracellu-
lar Hq concentration constant.
Treatment of monolayer cultures of Caco-2 cells
and SKPT cells with DEP for 10 min at pH 7.5 leads
to marked inhibition of Gly-Sar uptake. Studies on
the time-dependence of DEP-induced inhibition have
shown that maximal inhibition occurs with 10 min
 .treatment data not shown . Furthermore, we investi-
gated the concentration-dependence of the DEP effect
 .in both cell models Fig. 4 . The IC value for DEP50
inhibition was 0.39"0.04 mM in Caco-2 cells Fig.
.  .4A and 0.10"0.02 mM in SKPT cells Fig. 4B .
Therefore, in the following experiments we treated
the Caco-2 cells with 0.4 mM DEP and the SKPT
cells with 0.1 mM DEP.
3.4. Effect of DEP treatment on the kinetic parame-
ters of Gly-Sar uptake in intestinal and renal cells
We performed detailed kinetic studies at first to
determine if the inhibition of peptide uptake elicited
by DEP treatment is due to a decrease in the affinity
or a decrease in the maximal velocity of the transport
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systems. Cells were treated at pH 7.5 for 10 min with
the appropriate concentrations of DEP 0.4 mM for
.Caco-2; 0.1 mM for SKPT or ethanol. Cells were
then washed for 1 min with 1 ml buffer at pH 6.0.
Uptake of Gly-Sar was measured for 10 min over a
concentration range of 0.1–5 mM in Caco-2 cells and
0.01–0.5 mM in SKPT cells at an extracellular pH
6.0. The non-saturable transport component was again
subtracted from total uptake to calculate mediated
uptake as detailed in Section 2. The relationship
between the rate of mediated uptake and substrate
concentration was found to be hyperbolic in both cell
lines and both in control cells and in DEP-treated
 .cells Fig. 5A,B . The experimental data were found
to fit best for an uptake model describing a single
transport system. When expressed as Eadie-Hofstee
 .plots Fig. 5, insets , the data yielded straight lines
 2 .r )0.86 . Determination of kinetic parameters from
the data indicated that DEP treatment resulted in a
50% decrease of the maximal velocity of Gly-Sar
transport without changing significantly the affinity
of the carrier for Gly-Sar. In Caco-2 cells, the appar-
 .ent Michaelis-Menten constant K for the uptaket
process in control cells was 0.83"0.1 mM and the
corresponding value in DEP-treated cells was 0.76"
 .  .0.1 mM Table 2 . The maximal velocity V ofmax
Gly-Sar uptake, however, was 13.8"0.6 nmolr10
min per mg of protein in controls and 6.4"0.3
nmolr10 min per mg of protein in DEP-treated cells.
In SKPT cells, the apparent Michaelis-Menten con-
 .stant K for the uptake process in control cells wast
64.1"9.9 mM and the corresponding value in DEP-
 .treated cells was 62.3"4.5 mM Table 2 . The
 .maximal velocity V of Gly-Sar uptake, however,max
was 0.98"0.05 nmolr10 min per mg of protein in
the controls and 0.39"0.01 nmolr10 min per mg of
protein in DEP-treated cells. These data give no
evidence for an effect of DEP on the affinity of the
carrier protein to its substrate Gly-Sar in the intestinal
as well as in the renal cell line.
3.5. Effect of DEP-treatment on the IC ˝alues of50
Ala-Lys, Ala-Asp and cephalexin for inhibition of
Gly-Sar uptake in intestinal and renal cells
Similar to those experiments described earlier, we
performed studies with Ala-Lys, Ala-Asp and
cephalexin as inhibitors of Gly-Sar uptake in control
Fig. 5. Effect of DEP on the saturation kinetics of Gly-Sar uptake
 .  .in Caco-2 cells A and SKPT cells B . Uptake of Gly-Sar
concentration range, 0.25–5 mM in Caco-2 and 10–500 mM in
.SKPT, uptake time 10 min was measured at pH 6.0 in confluent
 .  . cell cultures after treatment with v or without ‘ DEP 0.4
.mM in Caco-2 cells, 0.1 mM in SKPT cells for 10 min at pH
7.5. The values are means"S.E.M. for 4–6 determinations. They
represent saturable uptake values after correction for non-satura-
ble component. If not shown, error bars are smaller than the
symbols. Insets: Eadie-Hofstee transformations of the data.
 .cells and in DEP-treated cells Fig. 6A,B . These data
were used to calculate IC values. As shown in50
Table 2, the DEP treatment does not change the IC50
values for Ala-Lys, Ala-Asp or cephalexin. These
results show that blockade of the function of histidyl
residues as a Hq acceptorrdonor with DEP treatment
does not influence the affinity of PEPT 1 and PEPT 2
for their substrates. These results are similar to those
obtained with reduced Hq concentration. It should be
 .noted that the affinity of PEPT 1 Caco-2 cells for
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cephalexin is 10- to 15-fold less than for Gly-Sar. In
 .contrast, the affinity of PEPT 2 SKPT cells for
cephalexin is comparable to the affinity for Gly-Sar.
Apparently, PEPT 1 and PEPT 2 exhibit significantly
different substrate recognition pattern.
w xKramer et al. 21 have demonstrated that DEP
treatment reduces the affinity of the intestinal
Hqrpeptide cotransporter for cephalexin. Our present
results are in contrast to those obtained by these
investigators. The reasons for the discrepancy are not
known. However, our results are in agreement with
w xthose of Kato et al. 19 which show no change upon
DEP treatment in the affinity of the intestinal
Hqrpeptide cotransporter for cephradine, also a zwit-
terionic aminocephalosporin similar to cephalexin.
Another interesting observation from our studies with
DEP is that the affinity of the peptide transporters for
Ala-Asp remains the same in control cells and in
DEP-treated cells. It has to be noted that these experi-
ments were done at a fixed extracellular pH of 6.0.
However, our studies with two different extracellular
pH values showed that the affinity of the peptide
transporters for Ala-Asp at pH 7.0 is much less than
at pH 6.0. Based upon the data from studies with
DEP, the apparent change in the affinity for Ala-Asp
at different extracellular pH is most likely an artifact,
resulting from pH-induced changes in the concentra-
tion of different ionic species of Ala-Asp.
In conclusion, we have investigated the influence
of Hq on the catalytic function of PEPT 1 and PEPT
2 using cell culture model systems by two different
approaches, namely by altering the extracellular Hq
concentration and by blocking the function of essen-
tial histidyl residues as Hq acceptorrdonor. The
results of the investigation demonstrate unequivocally
that Hq, which is the cotransported ion for PEPT 1
and PEPT 2, activates the transporters without influ-
encing the substrate affinity. The Hq gradient appar-
ently enhances the activity of PEPT 1 and PEPT 2
solely by increasing the translocation rate of the
transporters during the catalytic cycle. Our recent
work on the operational mechanisms of the cloned
w xhuman PEPT 1 supports this conclusion 45 . This is
Fig. 6. Effect of DEP on the inhibition of Gly-Sar uptake by
 .Ala-Lys, Ala-Asp and cephalexin in Caco-2 cells A and SKPT
 .  .cells B . Cells were treated for 10 min with v, B, ’ or
 . without ‘, I, ^ DEP 0.4 mM in Caco-2 cells, 0.1 mM in
.SKPT cells for 10 min at pH 7.5. Uptake of radiolabeled
 .Gly-Sar 10 mM in Caco-2, 5 mM in SKPT for 10 min was
measured in confluent cell cultures at pH 6.0 in the presence of
 .  .increasing concentrations of Ala-Lys ‘, v , Ala-Asp I, B
 .or cephalexin ^, ’ . The values are means for 3–6 determina-
 .tions. The standard error not shown was within 5–15% of the
mean.
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in contrast to the known role of Naq, the other major
coupling ion for active transport systems in animal
tissues, in increasing the affinity of the Naq-coupled
transporters for their substrates.
There have been two recent reports on the han-
dling of cationic and anionic peptides by peptide
w x w xtransporters 46,47 . Temple et al. 46 have shown
using renal brush border membrane vesicles that the
Hqrpeptide coupling ratio differs depending on the
net charge of the peptide substrate. The ratio is one
for zwitterionic peptides, two for anionic peptides,
and zero for cationic peptides. Since kidney expresses
PEPT 1 as well as PEPT 2, it is not readily apparent
whether these characteristics belong to PEPT 1 or
PEPT 2. Our most recent study with the cloned
human PEPT 1 has demonstrated that the Hqrpeptide
coupling ratio is one irrespective of the charge of the
w xpeptide substrate 48 . This may suggest that the
w xcharacteristics described by Temple et al. 45 belong
to PEPT 2. The present study does not address the
issue of Hqrpeptide coupling ratio for Ala-Asp and
Ala-Lys in SKPT cells nor does it probe the possible
differences in the Hq-dependence of the transport of
these peptides. What is analyzed in this study is not
the transport of Ala-Lys and Ala-Asp but the ability
of these peptides to compete with Gly-Sar for trans-
w xport. Wenzel et al. 47 have suggested that the rabbit
PEPT 1 accepts only the zwitterionic species of
peptidomimetic antibiotics as substrates. This means
that anionic and cationic peptide substrates would
have markedly different pH optima for their transport
via PEPT 1. But, the substrate-induced current by the
cloned human PEPT 1 in Xenopus lae˝is oocytes
exhibits comparable pH dependence for cationic and
w xanionic peptides 48 . It is obvious that more work is
needed to clearly define the possible differences in
the handling of peptide substrates of varied net
charges by the peptide transporters.
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